LXEO/ 10/07/2025 · 9:43 AM Lexeo's Friedreich Ataxia Treatment Accelerates FDA Review Lexeo Therapeutics' gene therapy, LX2006, is moving faster toward FDA approval for Friedreich's ataxia cardiomyopathy.
